1 |
Nelaturi P, Kademani SP, Siva Subramanian V, Ravikumar S. Noninvasive Biomarkers for Alcohol-Related Liver Disease—A Proteomic Related Preliminary Report. Ind J Clin Biochem 2023. [DOI: 10.1007/s12291-023-01120-9] [Reference Citation Analysis]
|
2 |
Marques P, Francisco V, Martínez-Arenas L, Carvalho-Gomes Â, Domingo E, Piqueras L, Berenguer M, Sanz MJ. Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease. Int J Mol Sci 2023;24. [PMID: 36768637 DOI: 10.3390/ijms24032313] [Reference Citation Analysis]
|
3 |
Ding JN, Feng TT, Sun W, Cai XY, Zhang Y, Zhao WF. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study. World J Gastrointest Surg 2022; 14(11): 1260-1271 [DOI: 10.4240/wjgs.v14.i11.1260] [Reference Citation Analysis]
|
4 |
Xu W, Li B, Yang Z, Li J, Liu F, Liu Y. Rethinking Liver Fibrosis Staging in Patients with Hepatocellular Carcinoma: New Insights from a Large Two-Center Cohort Study. J Hepatocell Carcinoma 2022;9:751-81. [PMID: 35983561 DOI: 10.2147/JHC.S372577] [Reference Citation Analysis]
|